Hugues, B. et al. 2022. Interleukin-1/6 Blockade for the Treatment of Severe Steroid-Refractory BNT162b2 Vaccine-Induced Adult-Onset Still’s Disease. European Journal of Case Reports in Internal Medicine. 9, 8 (Aug. 2022). DOI:https://doi.org/10.12890/2022_003469.